Semaglutide
Semaglutide image 1Semaglutide image 2
GLP-1 ResearchStandardReport Available

Semaglutide

Research overview

UWA Biotech Semaglutide with verified testing, multiple vial strengths and wholesale GLP-1 research supply.

Purity99.214%
Format5MG / 10MG / 15MG / 20MG / 30MG
Ships FromUnited States
MOQ10 vials / 1 box

Available variants

10 × 5MG$65.00In Stock
10 × 10MG$80.00In Stock
10 × 15MG$100.00In Stock
10 × 20MG$140.00In Stock
10 × 30MG$170.00In Stock

Product description

Product overview

Semaglutide is a GLP-1 receptor agonist supplied by UWA Biotech for laboratory investigations involving metabolic signalling pathways, peptide receptor activity and advanced research applications. Multiple vial strengths are available for wholesale box ordering.

Available formats

  • 10 × 5mg
  • 10 × 10mg
  • 10 × 15mg
  • 10 × 20mg
  • 10 × 30mg
  • MOQ: 10 vials / 1 box

Verification

  • Purity: 99.214%
  • Tested: 11 MAR 2025
  • Task number: #59302
  • Unique key: I5DRB3RENHKQ

Supply details

  • Supplier: UWA Biotech
  • Location: United States
  • Formats: 5mg–30mg options
  • Packaging: Wholesale 10-vial boxes
Research use only

This product is supplied exclusively for laboratory research use. Not for human consumption, medical treatment or clinical application.

Verification report

Report typeJanoshik / COA
Task number#59302
Unique IDI5DRB3RENHKQ
Tested11 MAR 2025
Open reportSemaglutide COA